Wockhardt shares ended trading at Rs.915.30 on Monday after having fallen as much as 14% in early trading
Shares of Wockhardt Ltd plunged almost 10% on Monday after the US Food and Drug Administration (FDA) on the weekend banned imports from the drug maker’s plant in Ankleshwar, Gujarat.
In its order on Friday, the FDA cited non-compliance with current good manufacturing practices (cGMPs) in slapping the ban on the active pharmaceutical ingredients plant.